Clinical Trial Update: Temsirolimus + Weekly Paclitaxel + Carboplatin for Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating temsirolimus with weekly paclitaxel and carboplatin for recurrent/metastatic head and neck squamous cell carcinoma; study completed w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• Temsirolimus (temsirolimus)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Squamous Cell Cancer, Head and Neck Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-06-26